BPM
JAZZ icon

Bowling Portfolio Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bowling Portfolio Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.06M Buy
15,468
+5,539
+56% +$842K 0.57% 51
2022
Q2 		$1.55M Sell
9,929
-92
-0.9% -$14.2K 0.39% 86
2022
Q1 		$1.56M Sell
10,021
-959
-9% -$139K 0.34% 107
2021
Q4 		$1.4M Sell
10,980
-687
-6% -$90.3K 0.29% 122
2021
Q3 		$1.52M Sell
11,667
-192
-2% -$29K 0.34% 106
2021
Q2 		$2.11M Sell
11,859
-26
-0.2% -$4.5K 0.47% 64
2021
Q1 		$1.95M Sell
11,885
-1,033
-8% -$170K 0.46% 68
2020
Q4 		$2.13M Sell
12,918
-932
-7% -$139K 0.5% 47
2020
Q3 		$1.98M Sell
13,850
-17,858
-56% -$2.21M 0.44% 45
2020
Q2 		$3.5M Sell
31,708
-536
-2% -$59.3K 0.75% 20
2020
Q1 		$3.22M Sell
32,244
-3,044
-9% -$394K 0.79% 19
2019
Q4 		$5.27M Sell
35,288
-2,543
-7% -$346K 0.9% 20
2019
Q3 		$4.85M Sell
37,831
-3,413
-8% -$458K 0.81% 20
2019
Q2 		$5.88M Buy
41,244
+27,055
+191% +$3.64M 0.96% 12
2019
Q1 		$2.03M Buy
+14,189
New +$1.85M 0.32% 95

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bowling Portfolio Management's JAZZ Position: Q3 2022 in Review

Bowling Portfolio Management increased its Jazz Pharmaceuticals (JAZZ) stake by 56% in Q3 2022, buying an estimated $842K and bringing the position to 15,468 shares worth $2.06M. The position accounts for 0.57% of the portfolio, ranked #51.

Bowling Portfolio Management first reported a position in JAZZ in Q1 2019 and has held it in 15 quarters since. The position peaked at $5.88M in Q2 2019. 468 funds tracked by Wall St. Rank hold JAZZ as of Q3 2022.

  • Bowling Portfolio Management held 15,468 shares of Jazz Pharmaceuticals worth $2.06M as of Q3 2022.
  • Bowling Portfolio Management bought 5,539 Jazz Pharmaceuticals shares in Q3 2022, an estimated $842K.
  • Jazz Pharmaceuticals made up 0.57% of Bowling Portfolio Management's portfolio in Q3 2022, its #51 holding.
  • Bowling Portfolio Management first reported a position in Jazz Pharmaceuticals in Q1 2019 and has held it in 15 quarters since.
  • Bowling Portfolio Management's Jazz Pharmaceuticals position peaked at $5.88M in Q2 2019.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2022.

Based on Bowling Portfolio Management's 13F filing for Q3 2022, filed 4 Oct 2022.